496 related articles for article (PubMed ID: 6603817)
1. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
Kikuchi K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
[TBL] [Abstract][Full Text] [Related]
2. B-cell malignancies and differentiation antigens defined with monoclonal antibodies.
Kikuchi K; Koshiba H; Kasai K; Hiratsuka H; Fujimoto N; Uede T
Jpn J Clin Oncol; 1983 Sep; 13(3):517-31. PubMed ID: 6417375
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of monoclonal antibodies recognizing three distinct differentiation antigens (BL1, BL2, BL3) on human B lymphocytes.
Wang CY; Azzo W; Al-Katib A; Chiorazzi N; Knowles DM
J Immunol; 1984 Aug; 133(2):684-91. PubMed ID: 6429242
[TBL] [Abstract][Full Text] [Related]
4. Human lymphocyte differentiation antigens HB-10 and HB-11. I. Ontogeny of antigen expression.
Tedder TF; Clement LT; Cooper MD
J Immunol; 1985 May; 134(5):2983-8. PubMed ID: 3156922
[TBL] [Abstract][Full Text] [Related]
5. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical evaluation of hematologic malignancies.
Miettinen M; Schwarting R; Hyun BH
Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
[TBL] [Abstract][Full Text] [Related]
7. [Use of monoclonal antibodies in the study of the lymphoid system. II. Classification and treatment of the leukemias].
Blanco Quirós A; Alvarez Guisasola J
An Esp Pediatr; 1982 Jul; 17(1):48-59. PubMed ID: 6982643
[TBL] [Abstract][Full Text] [Related]
8. [Phenotypic analysis of human T-cell lymphoma with reference to cell differentiation and morphological classification].
Feller AC
Veroff Pathol; 1989; 131():1-175. PubMed ID: 2694674
[TBL] [Abstract][Full Text] [Related]
9. A unique antigen on mature B cells defined by a monoclonal antibody.
Link MP; Bindl J; Meeker TC; Carswell C; Doss CA; Warnke RA; Levy R
J Immunol; 1986 Nov; 137(9):3013-8. PubMed ID: 3489782
[TBL] [Abstract][Full Text] [Related]
10. Surface marker expression of human B-cell lymphomas.
Ishii Y; Kokai Y; Yamaguchi A; Tsubota H; Kikuchi K
AIDS Res; 1986 Dec; 2 Suppl 1():S87-93. PubMed ID: 3493786
[TBL] [Abstract][Full Text] [Related]
11. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the clinical and biological significance of lymphoid phenotypes in acute leukemia.
Greaves MF
Cancer Res; 1981 Nov; 41(11 Pt 2):4752-66. PubMed ID: 7028250
[TBL] [Abstract][Full Text] [Related]
13. [Surface marker studies on lymphoma and leukemia cells with microcytotoxicity test using the UCLA Monoclonal Antibody Tray 5].
Toki H; Okabe K; Kimura Y; Fujii M; Tamai M; Moriwaki S; Yamamoto Y
Gan No Rinsho; 1985 Apr; 31(4):409-13. PubMed ID: 3874297
[TBL] [Abstract][Full Text] [Related]
14. Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential.
Epstein AL; Marder RJ; Winter JN; Stathopoulos E; Chen FM; Parker JW; Taylor CR
Cancer Res; 1987 Feb; 47(3):830-40. PubMed ID: 3542194
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies of IPO series against B cell differentiation antigens in leukemia and lymphoma immunophenotyping.
Sidorenko SP; Vetrova EP; Yurchenko OV; Berdova AG; Shlapatskaya LN; Gluzman DF
Neoplasma; 1992; 39(1):3-9. PubMed ID: 1528302
[TBL] [Abstract][Full Text] [Related]
16. Cell surface antigens expressed by subsets of pre-B cells and B cells.
McKearn JP; Baum C; Davie JM
J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
[TBL] [Abstract][Full Text] [Related]
17. [Monoclonal antibodies in the study of leukemia and lymphoma: new classification and prognostic criteria].
Pagnucco G
Riv Emoter Immunoematol; 1985; 32(2):227-45. PubMed ID: 2418486
[No Abstract] [Full Text] [Related]
18. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Dörken B; Moldenhauer G; Pezzutto A; Schwartz R; Feller A; Kiesel S; Nadler LM
J Immunol; 1986 Jun; 136(12):4470-9. PubMed ID: 3086431
[TBL] [Abstract][Full Text] [Related]
19. Tp44 molecules involved in antigen-independent T cell activation are expressed on human plasma cells.
Kozbor D; Moretta A; Messner HA; Moretta L; Croce CM
J Immunol; 1987 Jun; 138(12):4128-32. PubMed ID: 3035021
[TBL] [Abstract][Full Text] [Related]
20. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
